Interrogation of <i>IDH1</i> Status in Gliomas by Fourier Transform Infrared Spectroscopy


Cameron, James M, Conn, Justin JA, Rinaldi, Christopher, Sala, Alexandra, Brennan, Paul M, Jenkinson, Michael D ORCID: 0000-0003-4587-2139, Caldwell, Helen, Cinque, Gianfelice, Syed, Khaja, Butler, Holly J et al (show 3 more authors) (2020) Interrogation of <i>IDH1</i> Status in Gliomas by Fourier Transform Infrared Spectroscopy. CANCERS, 12 (12). E3682-.

Access the full-text of this item by clicking on the Open Access link.

Abstract

Mutations in the isocitrate dehydrogenase 1 (<i>IDH1</i>) gene are found in a high proportion of diffuse gliomas. The presence of the <i>IDH1</i> mutation is a valuable diagnostic, prognostic and predictive biomarker for the management of patients with glial tumours. Techniques involving vibrational spectroscopy, e.g., Fourier transform infrared (FTIR) spectroscopy, have previously demonstrated analytical capabilities for cancer detection, and have the potential to contribute to diagnostics. The implementation of FTIR microspectroscopy during surgical biopsy could present a fast, label-free method for molecular genetic classification. For example, the rapid determination of <i>IDH1</i> status in a patient with a glioma diagnosis could inform intra-operative decision-making between alternative surgical strategies. In this study, we utilized synchrotron-based FTIR microanalysis to probe tissue microarray sections from 79 glioma patients, and distinguished the positive class (<i>IDH1</i>-mutated) from the <i>IDH1</i>-wildtype glioma, with a sensitivity and specificity of 82.4% and 83.4%, respectively. We also examined the ability of attenuated total reflection (ATR)-FTIR spectroscopy in detecting the biomolecular events and global epigenetic and metabolic changes associated with mutations in the <i>IDH1</i> enzyme, in blood serum samples collected from an additional 72 brain tumour patients. Centrifugal filtration enhanced the diagnostic ability of the classification models, with balanced accuracies up to ~69%. Identification of the molecular status from blood serum prior to biopsy could further direct some patients to alternative treatment strategies.

Item Type: Article
Uncontrolled Keywords: biophotonics, infrared, imaging, cancer, histopathology, biofluids, glioma
Depositing User: Symplectic Admin
Date Deposited: 18 Dec 2020 13:58
Last Modified: 08 Feb 2024 17:57
DOI: 10.3390/cancers12123682
Open Access URL: https://www.mdpi.com/2072-6694/12/12/3682
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3110787
Dimensions
Altmetric
CORE (COnnecting REpositories)